Pseudotumour cerebri: Incidence, management and prevention

CNS Drugs

Volumn 14, Issue 1, 2000, Pages 33-49

  Gwan Go, K ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMPHOTERICIN B; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; DANAZOL; FUROSEMIDE; GLUCOCORTICOID; HORMONE; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; QUINOLONE DERIVATIVE; RETINOIC ACID; RETINOID; RETINOL; TETRACYCLINE;

BRAIN PSEUDOTUMOR; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; INTRACRANIAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 0033868212     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200014010-00004     Document Type: Review

References (206)

1. 1. Dandy WE. Intracranial pressure without brain tumour. Ann Surg 1937; 106: 492-513
2. 2. Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988; 45: 866-72
3. 3. Go KG. Cerebral Pathophysiology. An integral approach with some emphasis on clinical implications. Amsterdam: Elsevier, 1991
4. 4. Go KG. The normal and pathological physiology of brain water. Adv Tech Stand Neurosurg 1997; 23: 47-142
5. 5. Fishman RA. The pathophysiology of pseudotumor cerebri. An unsolved puzzle. Arch Neurol 1984; 41: 257-8
6. 6. Donaldson JO. Pathogenesis of pseudotumor cerebri syndromes. Neurology 1981; 31: 877-80
7. 7. Portnoy HD, Croissant PD. Megalencephaly in infants and children. The possible role of increased dural sinus pressure. Arch Neurol 1978; 35: 306-16
8. 8. Janny P, Chazal J, Colnet G, et al. Benign intracranial hypertension and disorders of CSF absorption. Surg Neurol 1981; 15: 168-74
9. 9. Ropper AH, Marmarou A. A mechanism of pseudotumor in Guillain-Barré syndrome. Arch Neurol 1984 Mar; 41: 259-61
10. 10. Morley JB, Reynolds EH. Papilloedema and the Landry-Guillain-Barré syndrome. Brain 1966; 89: 205-22
11. 11. Johnston I. Reduced CSF absorption syndrome, reappraisal of benign intracranial hypertension and related conditions. Lancet 1973; II: 418-21
12. 12. Hayes KC, McCombs HL, Faherty TP. The fine structure of vitamin A deficiency. II. Arachnoid granulations and CSF pressure. Brain 1971; 94: 213-24
13. 13. Siegel NJ, Spackman TJ. Chronic hypervitaminosis A with intracranial hypertension and low cerebrospinal fluid concentration of protein. Clin Pediatr 1972; 11: 580-4
14. 14. Conner EC, Foley L, Black PM. Experimental normal-pressure hydrocephalus is accompanied by in creased transmantle pressure. J Neurosurg 1984; 61: 322-7
15. 15. Weisberg LA. Benign intracranial hypertension. Medicine (Baltimore) 1975; 54: 197-207
16. 16. Mathew NT, Meyer JS, Ott EO. Increased cerebral blood volume in benign intracranial hypertension. Neurology 1975; 25: 646-9
17. 17. Raichle ME, Grubb RL, Phelps ME, et al. Cerebral hemodynamics and metabolism in pseudotumor cerebri. Ann Neurol 1978; 4: 104-11
18. 18. Brooks DJ, Beany RP, Leenders KL, et al. Regional cerebral oxygen utilization, blood flow, and blood volume in benign intracranial hypertension studied by positron emission tomography. Neurology 1985; 35: 1030-4
19. 19. Sahs AL, Joynt RJ. Brain swelling of unknown cause. Neurology 1956; 6: 791-803
20. 20. Van Harreveld A, Steiner J. Extracellular space in frozen and ethanol substituted central nervous tissue. Anat Rec 1970; 166 (1): 117-29
21. 21. Sorensen PS, Thomsen C, Gjerris F, et al. Brain water accumulation in pseudotumour cerebri demonstrated by MRI-imaging of brain water self-diffusion. Acta Neurochir 1990; Suppl. 51: 363-5
22. 22. Moser FG, Hilal SK, Abrams G, et al. MR imaging of pseudotumor cerebri. Am J Roentgenol 1988; 150: 903-9
23. 2-weighted MRI and spectroscopy. Magn Reson Med 1990; 14: 330-46
24. 24. Malozowski S, Tanner LA, Wysowski D, et al. Growth hormone, insulin-like growth factor I, and benign intracranial hypertension. N Engl J Med 1993 Aug; 329: 665-6
25. 25. Newton M, Cooper BT. Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease. Gut 1994; 35: 423-5
26. 26. Strack-Van Schijndel RJ, Bronsveld W, Boen-Tan TN. Een patiente met pseudotumor cerebri en lupus erythematodes. Ned Tijdschr Geneeskd 1986; 130: 123-6
27. 27. DelGiudice GC, Scher CA, Athreya BH, et al. Pseudotumor cerebri and childhood systemic lupus erythematosus. J Rheumatol 1986 Aug; 13: 748-52
28. 28. Vachvanichsanong P, Dissaneewate P. Childhood systemic lupus erythematosus in Songklanagarind hospital: a potential unique subgroup. Clin Rheumatol 1993; 12: 346-9
29. 29. Li EK, Chan MS. Is pseudotumor cerebri in SLE a thrombotic event? J Rheumatol 1990; 17: 983-4
30. 30. Orefice G, De Joanna G, Coppola M, et al. Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome? Lupus 1995; 4: 324-6
31. 31. Green L, Vinker S, Amital H, et al. Pseudotumor cerebri in systemic lupus erythematosus. Semin Arthritis Rheum 1995; 25: 103-8
32. 32. Ogawa M, Ishimaru K, Shiroto T, et al. A case of benign intracranial hypertension associated with systemic lupus erythematosus (SLE) showing diffuse white matter lesions on MRI. Rinsho Shinkeigaku 1994; 34: 577-81
33. 33. Akova YA, Kansu T, Duman S. Pseudotumor cerebri secondary to dural sinus thrombosis in neurosarcoidosis. J Clin Neuroophthalmol 1993; 13: 188-9
34. 34. Redwood MD, Winer JB, Rossor M. Neurosarcoidosis presenting as benign intracranial hypertension. Eur Neurol 1990; 30: 282-3
35. 35. Harper Jr CM, O'Neill BP, O'Duffy JD, et al. Intracranial hypertension in Behcet's disease: demonstration of sinus occlusion with use of digital subtraction angiography. Mayo Clin Proc 1985; 60: 419-22
36. 36. Shakir RA, Sulaiman K, Kahn RA, et al. Neurological presentation of neuro-Behcet's syndrome: clinical categories. Eur Neurol 1990; 30: 249-53
37. 37. Bosch JA, Valdes M, Solans R, et al. Skin hyper-reactivity in patients with benign intracranial hypertension as an early manifestation of Behcet's disease [letter]. Br J Rheumatol 1995; 34 (2): 184
38. 38. Confavreux C, Brunet P, Petiot P, et al. Congenital protein C deficiency and superior sagittal sinus thrombosis causing isolated intracranial hypertension. J Neurol Neurosurg Psychiatry 1994; 57: 655-7
39. 39. Enevoldsen TP, Russell RW. Cerebral venous thrombosis: new causes for an old syndrome? Q J Med 1990; 77: 1255-75
40. 40. Guymer RH, Cairns JD, O'Day J. Benign intracranial hypertension in chronic myeloid leukemia. Aust N Z J Ophthalmol 1993; 21 (3): 181-5
41. 41. Mestre C, Castrillo JM, Lopez-Ferro MO, et al. Seudotumor cerebral y anemia ferropenica. Rev Clin Esp 1986; 178: 337-9
42. 42. Buenaventura I, Matias-Guiu J, Davalos A, et al. Seudotumor cerebral y anemia ferropenica [letter]. Rev Clin Esp 1987; 180: 341
43. 43. Tugal O, Jacobson R, Berezin S, et al. Recurrent benign intracranial hypertension due to iron deficiency anemia. Case report and review of the literature. Am J Pediatr Hematol Oncol 1994; 16: 266-70
44. 44. Masumoto A, Yamamoto K, Umemura T, et al. A case of idiopathic autoimmune haemolytic anemia associated with benign intracranial hypertension. Rinsho-Ketsueki 1984; 25: 575-82
45. 45. Esack A, Thompson G, Burmester H. Benign intracranial hypertension and essential thrombocythaemia [letter]. J Neurol Neurosurg Psychiatry 1989; 52 (7): 914
46. 46. Thomas E. Recurrent benign intracranial hypertension associated with hemoglobin SC disease in pregnancy. Obstet Gynecol 1986; 67: 7S-9S
47. 47. Black DA, Forgacs I, Davies DR, et al. Pseudotumor cerebri in a patient with Castleman's disease. Postgrad Med J 1988; 64: 217-9
48. 48. Dela Pena A, Subtil JC, Rodriguez-Rosado R, et al. Sindrome POEMS, a proposito de dos casos y revision de la literatura. An Med Int 1996; 13: 291-4
49. 49. Barry JC, Gleichmann M, Wilhelm H. Beidseitige papillenschwellung bei polyneuropathie, organomegalie, endorkrinopathie, monoklonalen proteinen und hautveränderungen (POEMS Syndrom). Klin Monatsbl Augenheilkd 1999; 215: 59-63
50. 50. Wong VA, Wade NK. POEMS syndrome, an unusual cause of bilateral optic disk swelling. Am J Ophthalmol 1998; 126: 452-4
51. 51. Gatinel D, Larroche L, Fanjkuchen F. Oedème papillaire et syndrome POEMS. J Fr Ophthalmol 1998 Feb; 21: 133-41
52. 52. Raucher HS, Kaufman DM, Goldfarb J, et al. Pseudotumor cerebri and Lyme disease: a new association. J Pediatr 1985; 107: 931-3
53. 53. Jacobson DM, Frens DB. Pseudotumor cerebri syndrome associated with Lyme disease. Am J Ophthalmol 1989; 107: 81-2
54. 54. Belman AL, Iyer M, Coyle PK, et al. Neurologic manifestations in children with North American Lyme disease. Neurology 1993; 43: 2609-14
55. 55. Ellermann A, Hjelt K. Pseudotumor cerebri caused by Lyme borreliosis [comment]. Uheskr Laeger 1995; 157 (7): 901
56. 56. Morooka T, Hirata M, Fukuya H, et al. Pseudotumor cerebri associated with Yersinia pseudotuberculosis infection. Acta Paediatr 1994; 83: 456-7
57. 57. Prevett M, Harding AE. Intracranial hypertension following psittacosis. J Neurol Neurosurg Psychiatry 1993; 56: 425-6
58. 58. Traverso F, Stagnaro R, Fazio B. Benign intracranial hypertension associated with HIV infection. Eur Neurol 1993; 33: 191-2
59. 59. Schwartz S, Husstedt IW, Georgiadis D, et al. Benign intracranial hypertension in an HIV-infected patient: headaches as the only presenting sign. AIDS 1995; 9: 657-8
60. 60. El Ouahabi A, Lorenzo AV, Black PM. Study of pseudotumor cerebri in vitamin A deficient rabbit. Eur J Pediatr Surg 1992; 2 Suppl. 1: 43-4
61. 61. Roos RA, Van der Blij JF. Pseudotumor cerebri associated with hypovitaminosis A and hyperthyroidism. Dev Med Child Neurol 1985; 27: 246-8
62. 62. Navab M, Smith JE, Goodman DS. Rat plasma prealbumin. Metabolic studies on effects of vitamin A status and on tissue distribution. J Biol Chem 1977; 252 (6): 5107-14
63. 63. DeJong AR, Callahan CA, Weiss J. Pseudotumor cerebri and nutritional rickets. Eur J Pediatr 1985; 143: 219-20
64. 64. Bates GW, Whitworth NS, Parker JL, et al. Elevated cerebrospinal fluid prolactin concentration in women with pseudotumor cerebri. South Med J 1982; 75: 807-8
65. 65. Soelberg-Sorensen P, Gjerris F, Svenstrup B. Endocrine studies in patients with pseudotumor cerebri. Estrogen levels in blood and cerebrospinal fluid. Arch Neurol 1986; 43: 902-6
66. 66. Doczi T, Szerdahelyi P, Gulya K, et al. Brain water accumulation after the central administration of vasopressin. Neurosurgery 1982; 11: 402-7
67. 67. Reid AC, Teasdale GM, McCulloch J. Hormonal influence on water permeability across the blood-brain barrier. Clin Exp Neurol 1983; 19: 50-3
68. 68. Walsh FB. Papilledema associated with increased intracranial pressure in Addison's disease [abstract]. Arch Opthalmol 1952; 47: 86
69. 69. Alexandrakis G, Filatov V, Walsh T. Pseudotumor cerebri in a 12-year-old boy with Addison's disease. Am J Ophthalmol 1993; 116: 650-1
70. 70. Fischer EG, Anast CS. Pseudotumor cerebri following removal of an adrenocorticotropic hormone-secreting pituitary adenoma [letter]. Neurosurgery 1982; 10 (2): 297
71. 71. Press OW, Ladenson PW. Pseudotumor cerebri and hypothyroidism. Arch Int Med 1983; 143: 167-8
72. 72. Adams C, Dean HJ, Israels SJ, et al. Primary hypothyroidism with intracranial hypertension and pituitary hyperplasia. Pediatr Neurol 1994; 10: 166-8
73. 73. Tessler Z, Biender B, Yasun Y Papilloedema: benign intracranial hypertension in menarche. Ann Opthalmol 1985; 17: 76-7
74. 74. Deev AS, Chelnokova SN, Pchelinseva ZI, et al. O sindrome dobrokachestvennoi vnutricherepnoi gipertensii [Benign intracranial hypertension syndrome]. Klin Med Mosk 1990; 68: 41-3
75. 75. Shekleton P, Fidler J, Grimwade J. A case of benign intracranial hypertension in pregnancy. Br J Obstet Gynaecol 1980; 87: 345-7
76. 76. Henry SD, Jacques S. benign intracranial hypertension in pregnancy. JACEP 1979; 8 (8): 323-5
77. 77. Kassam SM, Hadi HA, Fadel HE, et al. Benign intracranial hypertension in pregnancy: current diagnostic and therapeutic approach. Obstet Gynecol Surv 1983; 38: 314-21
78. 78. Katz VL, Peterson R, Cefalo RC. Pseudotumor cerebri and pregnancy. Am J Perinatol 1989; 6: 442-5
79. 79. Sureda B, Alberca R. Hipertension intracraneal benigna y obesidad. Neurologia 1990; 5: 260-4
80. 80. Traviesa DC, Schwartzman RJ, Glaser JS, et al. Familial benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1976; 39: 420-3
81. 81. Sureda B, Alberca R. Embarazo e hipertension intracraneal benigna. An Med Int 1991; 8: 8-10
82. 82. Lesny P, Maguiness SD, Hay DM, et al. Ovarian hyperstimulation syndrome and benign intracranial hypertension in pregnancy after in-vitro fertilization and embryo transfer: case report. Human Reprod 1999; 14: 1953-5
83. 83. Orefice G, Striano S, Carrieri PB, et al. Benign intracranial hypertension of obese women. A twenty cases report. Acta Neurol Napoli 1984; 6: 186-92
84. 84. Noggle JD, Rodning CB. Rapidly advancing pseudotumor cerebri associated with morbid obesity; an indication for gastric exclusion. South Med J 1986; 79: 761-3
85. 85. Hannerz J, Greitz D, Ericson K. Is there a relationship between obesity and intracranial hypertension? Int J Obes Relat Metab Disord 1995; 19: 240-4
86. 86. Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45: 875-7
87. 87. Blethen SL, Allen DB, Graves D, et al. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the national cooperative growth study experience. J Clin Endocrinol Metab 1996; 81: 1704-10
88. 88. Lucidi V, Di Capua M, Rosati P, et al. Benign intracranial hypertension in an older child with cystic fibrosis. Pediatr Neurol 1993; 9: 494-5
89. 89. Nasr SZ, Schaffert D. Symptomatic increase in intracranial pressure following pancreatic enzyme replacement for cystic fibrosis. Pediatr Pulmonol 1995; 19: 396-7
90. 90. Bikangaga P, Canny GJ. Benign intracranial hypertension in infants with cystic fibrosis. Arch Pediatr Adolesc Med 1996; 150: 551-2
91. 91. Sheridan M, Johnston I. Hydrocephalus and pseudotumor cerebri in the mucopolysaccharidoses. Childs Nerv Syst 1994; 10: 148-50
92. 92. Castot A, Vincens M, Gamier R, et al. Hypertension intracranienne aigue probable après prise de minocycline chez le nourrison. Apropos de 3 cas. Thérapie 1983; 38: 93-9
93. 93. Pierog SH, Al Salihi FL, Cinotti D. Pseudotumor cerebri - a complication of tetracycline treatment of acne. J Adolesc Health Care 1986; 7: 139-40
94. 94. Brosset A, Nouaille Y, Merle L. Problèmes posés par la prescription des tétracyclines durant les premières années de vie. Rev Med Interne 1987; 8: 218-22
95. 95. Minutello JS, Dimayuga RG, Carter J. Pseudotumor cerebri, a rare adverse reaction to tetracycline therapy. A case report. J Periodontol 1988; 59: 848-51
96. 96. Lubetzki C, Sanson M, Cohen D, et al. Hypertension intracranienne bénigne et minocycline. Rev Neurol (Paris) 1998; 144 (3): 218-20
97. 97. Lander CM. Minocycline-induced benign intracranial hypertension. Clin Exp Neurol 1989; 26: 161-7
98. 98. Bove L, Compagnoni L, Lanzetti A, et al. Benign hypertension and minocycline. A case [in French; letter]. Rev Neurol (Paris) 1990; 146 (2): 158
99. 99. Gottfried NS. Pseudotumor cerebri and acne [letter]. Mil Med 1991; 156 (8): A5
100. 100. Donnet A, Dufour H, Graziani N, et al. Minocycline and benign intracranial hypertension. Biomed Pharmacother 1992; 46: 171-2
101. 101. Lewis PA, Kearney PJ. Pseudotumor cerebri induced by minocycline treatment for acne vulgaris [letter]. Acta Derm Venereol 1997; 77 (1): 83
102. 102. Weller B, Sharf B, Sierpinski-Barth J, et al. Idiopathic intracranial hypertension and tetracycline [in Hebrew]. Harefuah 1994; 127 (1-2): 9-11, 64
103. 103. Iordanescu C. Intracranial hypertension and tetracycline therapy. Oftalmologia 1993; 37: 152-3
104. 104. Moskowitz Y, Leibowitz E, Ronen M, et al. Pseudotumor cerebri induced by vitamin A combined with minocycline. Ann Ophthalmol 1993; 25: 306-98
105. 105. Delaney RA, Narayanaswamy TR, Wee D. Pseudotumor cerebri and acne [comment]. Mil Med 1990; 155 (10): 511
106. 106. Gardner K, Cox T, Digre KB. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review. Neurology 1995; 45: 6-10
107. 107. Kilpatrick C, Ebeling P. Intracranial hypertension in nalidixic acid therapy [letter]. Med J Aust 1982; 1 (6): 252
108. 108. Gedroyc W, Shorvon SD. Acute intracranial hypertension and nalidixic acid therapy. Neurology 1982; 32: 212-5
109. 109. Ulivelli A, Manelli F. Intossicazione acuta da acido nalicixico in un lattante. Minerva Pediatr 1984; 36: 55-9
110. 110. Mukherjee A, Dutta P, Lahiri M, et al. Benign intracranial hypertension after nalidix acid overdose in infants [letter]. Lancet 1990; 335 (8705): 1602
111. 111. Getenet JC, Croisile B, Vighetto A, et al. Idiopathic intracranial hypertension after ofloxacin treatment. Acta Neurol Scand 1993; 87: 503-4
112. 112. Winrow AP, Supramaniam G. Benign intracranial hypertension after ciprofloxacin administration. Arch Dis Child 1990; 65: 1165-6
113. 113. Atkin SL, Masson EA, Blumhardt LD, et al. Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonist. J Neurol Neurosurg Psychiatry 1994; 57: 371-2
114. 114. Askmark H, Lundberg PO, Olsson S. Drug-related headache. Headache 1989; 29: 441-4
115. 115. Korzets A, Rathaus M, Chen B, et al. Pseudotumor cerebri and nitrofurantoin [letter]. Drug Intell Clin Pharm 1988; 22 (4): 345
116. 116. Heudier P, Chichmanian RM, Taillan B, et al. Hypertension intracranienne bénigne médicamenteuse. A propos d'un cas rapport a l'amphotéricine B. Revue de la littérature. Thérapie 1992; 47: 403-7
117. 117. Gangemi M, Maiuri F, Di Martino L, et al. Intracranial hypertension due to acute vitamin A intoxication. Acta Neurol Napoli 1985; 7: 27-31
118. 118. Bhettay EM, Bakst CM. Hypervitaminosis A causing benign intracranial hypertension. A case report. S Afr Med J 1988; 74: 584-5
119. 119. Sharieff GQ, Hanten K. Pseudotumor cerebri and hypercalcemia resulting from vitamin A toxicity. Ann Emerg Med 1996; 27: 518-21
120. 120. Drouet A, Valance J. Hypertension intracranienne bénigne et hypervitaminose A chronique. Rev Neurol Paris 1998; 154: 253-6
121. 121. Amrani Y, Terriza F, Moreno C, et al. Pseudotumor cerebri por hipervitaminosis debida a ingesta excesiva de leche enriqueda con vitaminas A + D. Rev Neurol 1996; 24: 1304-5
122. 122. Baqui AH, de Francisco A, Arifeen SE, et al. Bulging fontanelle after supplementation with 25,000 IU of vitamin A in infancy using immunization contacts. Acta Pediatr 1995; 84: 863-6
123. 123. Selhorst JB, Waybright EA, Jennings S, et al. Liver lover's headache: pseudotumor cerebri and vitamin A intoxication [letter]. JAMA 1984; 252 (24): 3365
124. 124. Sirdovsky M, Kattah J, Macedo P. Intracranial hypertension in a dieting patient. J Neuroophthalmol 1994; 14: 9-11
125. 125. Herbert J, Wilcox JN, Kim-Thu CP, et al. Transthyretin: a choroid plexus specific transport protein in human brain. Neurology 1986; 36: 900-11
126. 126. Becker NH, Sutton CH. Pathologic features of the choroid plexus: cytochemical effects of hypervitaminosis A. Am J Pathol 1963; 43: 1017-30
127. 127. Varadi G, Lossos A, Or R, et al. Successful allogeneic bone marrow transplantation in a patient with ATRA-induced pseudotumor cerebri. Am J Hematol 1995; 50: 147-8
128. 128. Visani G, Manfroi S, Tosi P, et al. All-trans retinoic acid and pseudotumor cerebri. Leuk Lymphoma 1996; 23: 437-42
129. 129. Selleri C, Pane F, Notaro R, et al. All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukemia followed by ATRA-induced pseudotumor cerebri. Br J Haematol 1996; 92: 937-40
130. 130. Decaudin D, Adams D, Naccache P, et al. Maintained all-trans retinoic acid therapy in a patient with pseudotumor cerebri despite aggravated symptoms. Leuk Lymphoma 1997; 27: 373-4
131. 131. Tanaka T, Akifuji Y, Mori M, et al. Intracranial hypertension in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid. Rinsho-Ketsueki 1997; 38: 47-51
132. 132. Sano F, Tsuji K, Kunika N, et al. Pseudotumor cerebri in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid. Intern Med 1998; 37: 546-9
133. 133. Smith MA, Adamson PC, Balis FM, et al. Phase I and pharmacokinetic evaluation of all-trans retinoic acid in pediatric patients with cancer. J Clin Oncol 1992; 10: 1666-73
134. 134. Adamson PC, Reaman G, Finklestein JZ, et al. Phase I trial and pharmacokinetic study of all-trans retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer. J Clin Oncol 1997; 15 (11): 3330-7
135. 135. Mahmoud HH, Hurwitz CA, Roberts WM, et al. Tretinoin toxicity in children with acute promyelocytic leukaemia. Lancet 1993; 342: 1394-5
136. 136. Yokokura M, Hatake K, Komatsu N, et al. Toxicity of tretinoin in acute promyelocytic leukaemia. Lancet 1994; 343: 361-2
137. 137. de Lacerda JF. Toxicity of tretinoin in acute promyelocytic leukaemia. Lancet 1994; 343: 360-1
138. 138. Spector RH, Carlisle J. Pseudotumor cerebri caused by a synthetic vitamin A preparation. Neurology 1984; 34: 1509-11
139. 139. Roytman M, Frumkin A, Bohn TG. Pseudotumor cerebri caused by isotretinoin. Cutis 1988; 42: 399-400
140. 140. Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 1995; 55: 165-8
141. 141. Bigby M, Stern RS. Adverse reactions to isotretinoin. A report from the adverse drug reaction reporting system. J Am Acad Dermatol 1988; 18: 543-52
142. 142. Sunku AJ, O'Duffy AE, Swanson JW. Benign intracranial hypertension associated with levonorgestrel implants. Ann Neurol 1993; 34: 299
143. 143. Alder JB, Fraunfelder FT, Edwards R. Levonorgestrel implants and intracranial hypertension. N Engl J Med 1995; 332: 1720-1
144. 144. Wysowski DK, Green L. Serious adverse events in Norplant users reported to the food and drug administration's med-Watch spontaneous reporting system. Obstet Gynecol 1995; 85: 538-42
145. 145. Shah A, Roberts T, McQueen IN, et al. Danazol and benign intracranial hypertension. Br Med J (Clin Res Ed) 1987; 294 (6583): 1323
146. 146. Hamed LM, Glaser JS, Schatz NJ, et al. Pseudotumor cerebri induced by danazol. Am J Ophthalmol 1989; 107: 105-10
147. 147. Pears J, Sandercock PA. Benign intracranial hypertension associated with danazol. Scott Med J 1990; 35 (2): 49
148. 148. Loukili M, Cordonnier M, Capelluto E, et al. Pseudotumeur cerebri induit par danazol. Bull Soc Belge Ophthalmol 1990; 239: 139-44
149. 149. Fanous M, Hamed LM, Margo CE. Pseudotumor cerebri associated with danazol withdrawal. JAMA 1991; 266: 1218-9
150. 150. Schmitz U, Honisch C, Zierz S. Pseudotumor cerebri and carpal tunnel syndrome associated with danazol therapy [letter]. J Neurol 1991; 238 (6): 355
151. 151. Gray RG. Bilateral carpal tunnel syndrome and arthritis with danazol administration. Arthritis Rheum 1998; 21: 493-4
152. 152. Sikka A, Kemmann E, Vrablik RM, et al. Carpal tunnel syndrome associated with danazol therapy. Am J Obstet Gynecol 1983; 147: 102-3
153. 153. Malozowski S, Tanner LA, Wysowski DK, et al. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr 1995; 126: 996-9
154. 154. Bermudez de la Vega JA, Martinez-Martinez JJ, Fernandez-Fiscer P, et al. Hipertension intracraneal benigna como efecto secundario del tratamiento con hormona de crecimiento biosintetica. An Esp Pediatr 1996; 44: 507-8
155. 155. Querfeld U. Benign intracranial hypertension (pseudotumor cerebri) during rhGH therapy [abstract]. Br J Clin Pract Symp Suppl. 1996; 85: 68
156. 156. Francois I, Casteels I, Silberstein J, et al. Empty sella, growth hormone deficiency and pseudotumor cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy. Eur J Pediatr 1997; 156: 69-70
157. 157. Werther GA, Hogg A, McKinley M, et al. Localization and characterization of IGF-I receptors in rat brain and pituitary gland using in-vitro autoradiography and computerized densitometry. J Neuroendocrinol 1989; 1: 370-7
158. 158. Ho KY, Weissberger AJ. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system. Metabolism 1990; 39: 133-7
159. 159. Lordereau-Richard I, Roger M, Chaussin JL. Transient bilateral papilloedema in a 10-year-old boy treated with recombinant insulin-like growth factor I for growth hormone receptor deficiency. Acta Paediatr Suppl. 1994; 399: 152
160. 160. Arber N, Shirin H, Fadila R, et al. Pseudotumor cerebri associated with leuprorelin acetate [letter]. Lancet 1990; 335 (8690): 668
161. 161. Boot JH. Pseudotumor cerebri as a side effect of leuprorelin acetate [letter]. Ir J Med Sci 1996; 165 (1): 60
162. 162. Haller JS, Meyer DR, Cromie W, et al. Pseudotumor cerebri following beta-human chorionic gonadotrophin hormone treatment for undescended testicles. Neurology 1993; 43: 448-9
163. 163. Antaraki A, Piadites G, Vergados J, et al. Octeotride in benign intracranial hypertension [letter]. Lancet 1993; 342 (8880): 1170
164. 164. McVie R. Abnormal TSH regulation, pseudotumor cerebri, and empty sella after replacement therapy in juvenile hypothyroidism. J Pediatr 1984; 105: 768-70
165. 165. Huseman CA, Torkelson RD. Pseudotumor cerebri following treatment of hypothalamic and primary hypothyroidism. Am J Dis Child 1984; 138: 927-31
166. 166. Rohn R. Pseudotumor cerebri following treatment of hypothyroidism [letter]. Am J Dis Child 1985; 139 (8): 752
167. 167. Panza N, De Rosa M, Lombardi G, et al. Pseudotumor cerebri and thyroid replacement therapy in patients affected by differentiated thyroid carcinoma. J Endocrinol Invest 1985; 8: 357-8
168. 168. Misra M, Khan GM, Rath S. Eltroxin induced pseudotumor cerebri - a case report. Indian J Ophthalmol 1993; 40: 117
169. 169. Campos SP, Olitsky S. Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism. Clin Pediatr Phila 1995; 34: 334-7
170. 170. Williams JB. Adverse effects of thyroidhormones. Drugs Aging 1997; 11: 460-9
171. 171. Raghavan S, DiMartino-Nardi J, Saenger P, et al. Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr 1997; 130: 478-80
172. 172. Cordon-Lopez A, Munoz-Lopez A, Fernandez-Jimenez S, et al. Acute intracranial hypertension during amiodarone infusion. Crit Care Med 1985; 13: 688-9
173. 173. Fikkers BG, Bogousslavsky J, Regli F, et al. Pseudotumor cerebri with amiodarone [letter]. J Neurol Neurosurg Psychiatry 1986; 49 (5): 606
174. 174. Van Zandijcke M, Dewachter A. Pseudotumor cerebri with amiodarone. J Neurol Neurosurg Psychiatry 1986; 49: 1463-4
175. 175. Grogan WA, Narkun DM. Pseudotumor cerebri with amiodarone [letter]. J Neurol Neurosurg Psychiatry 1987; 50 (5): 651
176. 176. Borruat FX, Regli F. Pseudotumor cerebri as a complication of amiodarone therapy. Am J Ophthalmol 1993; 116: 776-7
177. 177. Ahmad S. Amiodarone and reversible benign intracranial hypertension [letter]. Cardiology 1996; 87: 90
178. 178. Mayer-Hubner B. Pseudotumor cerebri from intranasal oxytocin and excessive fluid intake [letter]. Lancet 1996; 347 (9001): 623
179. 179. Liu GT, Kay MD, Bienfang DC, et al. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol 1994; 117: 352-7
180. 180. Cardinale A, Rosati C, Giani I, et al. Pseudotumor cerebri da sospensione di corticosteroidi. Presentazione di un caso. Minerva Pediatr 1991; 43: 457-60
181. 181. Parfitt VJ, Dearlove JC, Savage D, et al. Benign intracranial hypertension after pituitary surgery for Cushing's disease. Postgrad Med J 1994; 70: 115-7
182. 182. Cruz OA, Fogg SG, Roper-Hall G. Pseudotumor cerebri associated with cyclosporine use. Am J Ophthalmol 1996; 122: 436-7
183. 183. Schowengerdt KO, Gajarski RJ, Denfield S. Progressive visual deterioration leading to blindness after pediatric heart transplantation. Tex Heart Inst J 1993; 20: 299-303
184. 184. Evers JP, Jacobson RJ, Pincus J, et al. Pseudotumor cerebri following high-dose cytosine arabinoside. Br J Haematol 1992; 80: 559-60
185. 185. Falchuk SC, Spitzer TR, Deeg HJ. Pseudotumor cerebri after ABMT. Bone Marrow Transplant 1990; 6: 152-3
186. 186. Marsh LF, Morgan AL, Jefferson D. Benign intracranial hypertension during chemotherapy for testicular teratoma. Br J Radiol 1988; 61: 692
187. 187. Chabrol H, Netter JC, Carriere JP. Hypertension intracranienne bénigne chez un enfant traité par miansérine [letter]. Arch Fr Pediatr 1982; 39 (8): 650
188. 188. Heuser M, Heuser H. Pseudotumor following insecticide (lindane) intoxication. Acta Univ Carol Med 1976; 75: 133-5
189. 189. Verderber L, Lavin P, Wesley R. Pseudotumor cerebri and chronic benzene hexachloride (lindane) exposure [letter]. J Neurol Neurosurg Psychiatry 1991; 54 (12): 1123
190. 190. Saul RF, Hamburger HA, Selhorst JB. Pseudotumor cerebri secondary to lithium carbonate. JAMA 1985; 253: 2869-70
191. 191. Alvarez-Cermeno JC, Fernandez JM, O'Neill A, et al. Lithium-induced headache. Headache 1989; 29: 246-7
192. 192. Moral-Iglesias L, O'Neill of Tyrone A, Alvarez-Cermeno C, et al. Hipertension craneal benigna secundaria a tratamiento con litio. Actas Luso Esp Neurol Psiquitr Cienc Afines 1989; 17: 251-3
193. 193. Levine SH, Puchalski C. Pseudotumor cerebri associated with lithium therapy in two patients. J Clin Psychiatry 1990; 51: 251-3
194. 194. Dommise J. Pseudotumor cerebri associated with lithium therapy in two patients [letter]. J Clin Psychiatry 1991; 52: 239
195. 195. Ames D, Wirshing WC, Cokely HT, et al. The natural course of pseudotumor cerebri in lithium treated patients. J Clin Psychopharmacol 1994; 14: 286-7
196. 196. Go KG, Houthoff HJ, Hartsuiker J, et al. Fluid secretion in arachnoid cysts as a clue to cerebrospinal fluid absorption at the arachnoid granulation. J Neurosurg 1986; 65: 642-8
197. 197. Falcini F, Taccetti G, Montanelli F, et al. Ipertensione endocranica benigna in corso di terapia con acido acetilsalicilico: segnalazione di due casi in eta pediatrica. Pediatr Med Chir 1989; 11: 319-21
198. 198. Johnson LN, Krohel GB, Madsen RW, et al. The role of eight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998; 105: 2313-7
199. 199. Wandstrat TL, Phillips J. Pseudotumor cerebri responsive to acetazolamide [case report]. Ann Pharmacother 1995; 29: 318
200. 200. Krogsaa B, Soerensen PS, Seedorf HH, et al. Ophthamologic prognosis in benign intracranial hypertension. Acta Ophthalmol 1985; 63 Suppl. 173: 62-4
201. 201. Guidetti B, Giuffrè R, Gambacorta D. Follow-up study of 100 cases of pseudotumor cerebri. Acta Neurochir (Wien) 1968; 18 (4): 259-67
202. 202. Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol 1994; 118: 88-96
203. 203. Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Arch Neurol 1989; 46: 1049-51
204. 204. Karahalios DG, Rekate HL, Khayata MH, et al. Elevated intracranial pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996; 46: 198-202
205. 205. Brourman ND, Spoor TC, Ramocki JM. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1988; 106: 1378-83
206. 206. Spoor TC, Ramocki JM, Madion MP, et al. Treatment of pseudotumor cererbi by primary and secondary optic nerve sheath decompression. Am J Ophthalmol 1991; 112: 177-85